Companies · Medical Devices

Tally Surgical, Inc.

Irvine · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Tally Surgical, Inc. — recommendation, valuation, rhythm, risks.
$11.6M
Total raised · real
5
Rounds
14.7×
Latest step-up
Top 20%
Sector rank · raised
Series A
Latest stage · inferred · Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Tally Surgical, Inc. looks fair against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.67× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era.
  • Within the normal band (67% of peer median) for its niche.
Quiet
  • Last raise 2.2 yr ago; this sector typically re-raises about every 16 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Tally Surgical, Inc. is one of 233 Medical Devices companies tracked from Irvine. By capital raised it ranks in the upper tier (ahead of 81% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2020
Year incorporated
2024-04-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2020-03-03 Raised $1.8M (real) Modeled valuation $52M (est)$1.8M$52MSeed2020Seed · 2022-07-04 Raised $100K (real) Modeled valuation $1.2M (est)$100K$1.2MSeed2022Seed · 2022-09-27 Raised $2.0M (real) Modeled valuation $21M (est)$2.0M$21MSeed2022Seed · 2023-09-25 Raised $490K (real) Modeled valuation $3.2M (est)$490K$3.2MSeed2023Series A · 2024-04-15 Raised $7.2M (real) Modeled valuation $39M (est)$7.2M$39MSeries A2024+$100K+$2.0M+$490K+$7.2MCumulative $12M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.8M · 2020
Seed extension$100K · 2022
Seed extension$2.0M · 2022
Seed extension$490K · 2023
Series A$7.2M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$38.8M
Base estimate est.
$8.8M
Conservative case
$88.1M
Upside case
$32.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Seed · modeled $51.9M · 2020-03-032020Seed · modeled $1.2M · 2022-07-04Seed · modeled $21.4M · 2022-09-27Seed · modeled $3.2M · 2023-09-25Series A · modeled $38.8M · 2024-04-152024
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.49×/yr
Annual markup
1.87×/yr upside case
2.2 yr
Elapsed time used
2.2 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$2.8M/yr
Capital velocity
6.3 yr
On record since
2020
First round
5
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.5× above median
This company$11.6M
Sector median$2.6M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.6× above median
This company$7.2M
Sector median$4.6M
Modeled value — vs sector median (estimate, all stages) 2.5× above median
This company$38.8M
Sector median$15.4M

Raised more than 81% of sector peers (real $). Modeled value above 74% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #8 of 13.

This companyCohort peer
$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)MBio Diagnostics, Inc. · Series A Raised $45.3M · modeled $77.4M (est)Vida Diagnostics Inc · Series A Raised $32.0M · modeled $73.8M (est)New View Surgical, Inc. · Series A Raised $15.8M · modeled $70.8M (est)Thunder Road Surgical, Llc · Series A Raised $5.8M · modeled $62.8M (est)Barsa Surgical Inc. · Series A Raised $10.0M · modeled $60.8M (est)Caire Health Holdings, Inc. · Series A Raised $6.7M · modeled $57.9M (est)Moichor Inc · Series A Raised $11.3M · modeled $57.7M (est)Hyperion Surgical, Inc. · Series A Raised $6.0M · modeled $38.8M (est)Minute Molecular Diagnostics, Inc. · Series A Raised $11.3M · modeled $35.0M (est)Acuamark Diagnostics, Inc. · Series A Raised $20.3M · modeled $25.6M (est)Checkpoint Surgical, Inc. · Series A Raised $35.2M · modeled $20.8M (est)Tally Surgical, Inc. (this company) Raised $11.6M · modeled $38.8M (est)Tally Surgical, Inc.
CompanyStageRaised · realValue · estvs peer med.
MBio Diagnostics, Inc.Series A$45.3M$77.4M1.34×
Vida Diagnostics IncSeries A$32.0M$73.8M1.28×
New View Surgical, Inc.Series A$15.8M$70.8M1.23×
Thunder Road Surgical, LlcSeries A$5.8M$62.8M1.09×
Barsa Surgical Inc.Series A$10.0M$60.8M1.05×
Caire Health Holdings, Inc.Series A$6.7M$57.9M1.00×
Moichor IncSeries A$11.3M$57.7M1.00×
Tally Surgical, Inc. this companySeries A$11.6M$38.8M0.67×
Hyperion Surgical, Inc.Series A$6.0M$38.8M0.67×
Minute Molecular Diagnostics, Inc.Series A$11.3M$35.0M0.61×
Acuamark Diagnostics, Inc.Series A$20.3M$25.6M0.44×
Checkpoint Surgical, Inc.Series A$35.2M$20.8M0.36×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.8M2020-03-03$8.8M$51.9M90%
Seed$100K2022-07-04$500K$1.2M90%
Seed$2.0M2022-09-27$10.2M$21.4M90%
Seed$490K2023-09-25$2.5M$3.2M90%
Series A$7.2M2024-04-15$32.7M$38.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.8M2020-03-03
    • First recorded raise — entered as Seed.
    • 12 investors on this round.
  2. Seed$100K2022-07-04
    • Raised again after 28 mo — slower than the ~16 mo sector norm.
    • Round 17.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  3. Seed$2.0M2022-09-27
    • Came back fast: 3 mo vs the ~16 mo sector norm.
    • Round 20.5× larger than the prior — scaling up.
    • 9 investors on this round.
  4. Seed$490K2023-09-25
    • Raised 12 mo later, in step with the ~16 mo sector norm.
    • Round 4.2× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  5. Series A$7.2M2024-04-15
    • Came back fast: 7 mo vs the ~16 mo sector norm.
    • Round 14.7× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2025 ~Q2
Modeled next raise · ~12mo cadence
$21.6M
Modeled next size est.range $14.0M$34.5M
14.7×
Last step-up
$2.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Dreyer2 other2024-04
Jason Grimes2 other2022-09
Stavros Vizirgianakis2 other2022-09
Brian Stewart1 other2020-03
David A. Dreyer2022-09
Stephen A. Inacker2022-09
Stephen Inacker2024-04
Registry & provenance

Tally Surgical, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1806896
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Minute Molecular Diagnostics, Inc.Medical DevicesSeries A$11.3M$35.0Msame sector · same stage
Moichor IncMedical DevicesSeries A$11.3M$57.7Msame sector · same stage
ExplORer Surgical Corp.Medical DevicesSeries A$11.2M$45.9Msame sector · same stage
Nanomedical Diagnostics, Inc.Medical DevicesSeries A$12.0M$38.0Msame sector · same stage
Emerge Diagnostics, IncMedical DevicesSeries A$12.0M$688Ksame sector · same stage
SafeOp Surgical, Inc.Medical DevicesSeries A$10.9M$136.4Msame sector · same stage
Reliant Immune Diagnostics, Inc.Medical DevicesSeries A$10.9M$262.4Msame sector · same stage
Surgical Center of Greensboro, LLCMedical DevicesSeries A$12.4M$2.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Sure Count Surgical, LLCMedical DevicesSeed$73.6M89%
ReadySet Surgical, Inc.Medical DevicesSeries A$7.6M84%
Alliance Surgical Center, LLCMedical DevicesPre-Seed$459K84%
Buck Surgical, Inc.Medical DevicesPre-Seed$870K83%
Derry Surgical Center, LLCMedical DevicesPre-Seed$765K83%
Checkpoint Surgical, Inc.Medical DevicesSeries A$20.8M83%
Pace Surgical, Inc.Medical DevicesSeed$3.4M83%
Greenway Surgical Suites, LLCMedical DevicesPre-Seed$2.9M82%
Frequently asked
How much funding has Tally Surgical, Inc. raised?
Tally Surgical, Inc. has raised approximately $11.6M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Tally Surgical, Inc.'s estimated valuation?
Provath's modeled valuation for Tally Surgical, Inc. is approximately $38.8M (modeled range $8.8M–$88.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Tally Surgical, Inc. at?
Tally Surgical, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Apr 15.
What does Tally Surgical, Inc. do and where is it based?
Tally Surgical, Inc. operates in the Medical Devices sector, based in Irvine.
Explore related

See where Tally Surgical, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Tally Surgical, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.